Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N,N'-Disuccinimidyl Carbonate

    • Product Name N,N'-Disuccinimidyl Carbonate
    • Alias DSC
    • Einecs 431-030-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    790440

    Chemical Name N,N'-Disuccinimidyl Carbonate
    Abbreviation DSC
    Cas Number 74124-79-1
    Molecular Formula C9H10N2O8
    Molecular Weight 274.19 g/mol
    Appearance White to off-white crystalline powder
    Melting Point 74-77°C
    Solubility Soluble in DMSO, DMF, and acetone; slightly soluble in water
    Storage Temperature 2-8°C (refrigerated)
    Application Used as a reagent for the activation of alcohols and amines in organic synthesis
    Synonyms Disuccinimidyl carbonate; Carbonic acid disuccinimidyl ester
    Purity Typically ≥98%
    Stability Sensitive to moisture
    Safety Hazard Labelling Irritant

    As an accredited N,N'-Disuccinimidyl Carbonate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing N,N'-Disuccinimidyl Carbonate, 5 grams, is supplied in a sealed amber glass bottle with tamper-evident cap and desiccant pouch.
    Shipping N,N'-Disuccinimidyl Carbonate is shipped in tightly sealed containers, under dry, cool conditions to prevent moisture exposure and degradation. It is typically packed in amber glass bottles or plastic containers, cushioned against impact, and labeled as a hazardous material. Shipping must comply with local and international chemical transport regulations.
    Storage N,N'-Disuccinimidyl Carbonate should be stored in a tightly sealed container, protected from moisture and light, at 2–8°C (refrigerated). The storage area should be well-ventilated and designated for chemicals. Avoid exposure to heat, humidity, and acidic or basic substances. Proper storage ensures stability, prevents hydrolysis, and maintains reagent quality for use in chemical synthesis or bioconjugation processes.
    Application of N,N'-Disuccinimidyl Carbonate

    Applications of N,N'-Disuccinimidyl Carbonate in Industrial Manufacturing

    N,N'-Disuccinimidyl Carbonate serves as a high-activity coupling reagent essential for precision downstream synthesis in several chemical process industries. As a direct manufacturer, we optimize reactivity and batch-to-batch consistency to support specific industry standards and advanced formulation needs. Below are detailed application scenarios covering regulated fields and specialized production workflows.

    1. Activated Ester Synthesis for Peptide Manufacturing

    Pharmaceutical peptide producers utilize N,N'-Disuccinimidyl Carbonate to generate activated esters, offering high yield amidation while maintaining low racemization rates and controlled side-product formation. The material’s reliable performance supports critical step coupling, especially in solid-phase peptide synthesis (SPPS) and solution-phase assembly lines. Process engineers select this reagent to maintain purity profiles that meet regulatory acceptance, ensuring final peptides comply with stringent global pharmacopoeial requirements for APIs used in parenteral preparations.

    Industry compliance standards

    • United States Pharmacopeia (USP)
    • European Pharmacopoeia (Ph. Eur.)
    • Japan Pharmacopoeia (JP)
    • ICH Q7 GMP Guidelines

    Typical usage ratio

    • 1.0–1.2 equivalents relative to peptide carboxyl group; ratio adjusted for resin loading or free amino concentration to minimize excess reagent and achieve optimal coupling efficiency.

    Downstream process integration

    • Introduced directly after deprotection and wash steps in SPPS cycles during the activation of C-terminal carboxyl groups.
    • Used in acylation reactors for solution-phase peptide bond construction under anhydrous conditions.
    • Handled in closed-system isolation rooms to prevent hydrolysis.

    Final product types

    • Clinical-grade active pharmaceutical peptides
    • Peptide diagnostics and research reagents
    • Peptide intermediates for conjugate vaccines
    • Synthetic oligopeptide APIs

    2. Antibody–Drug Conjugate (ADC) Linker Attachment in Biopharmaceuticals

    CDMO and biopharma production sites deploy this carbonate reagent for controlled activation of terminal amines on antibody or drug payload molecules. Its use in ADC manufacturing ensures homogeneous linker-to-antibody ratio (DAR) distributions and maintains protein integrity by avoiding harsh reaction conditions. The reagent supports batch reproducibility and facilitates in-process monitoring in GMP-regulated environments, especially as ADC regulatory filings mandate strict documentation of linker chemistries and impurity profiles.

    Industry compliance standards

    • U.S. FDA cGMP (21 CFR Part 210/211)
    • EMA GMP (EudraLex, Volume 4)
    • ICH Q6B Specifications for Biotechnological/Biological Products
    • USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products

    Typical usage ratio

    • 1.1–1.5 molar equivalents per antibody molecule; determined by antibody concentration and desired DAR target. Adjustment required for payload molecular structure.

    Downstream process integration

    • Added during the linker synthesis or conjugation phase following antibody buffer exchange.
    • Used in aqueous or mixed solvent media under nitrogen, with purification via tangential flow filtration (TFF) or SEC.
    • Subjected to continuous in-process QC sampling for residuals.

    Final product types

    • Antibody–drug conjugates (oncology therapeutics)
    • Site-specific protein–drug conjugates
    • Research-grade bioconjugates for target validation
    • Platform ADC linker intermediates

    3. Active Surface Modification of Medical Diagnostics Polymers

    Manufacturers of in-vitro diagnostic components use this coupling reagent for surface activation of polymeric microplates, beads, or membranes, introducing NHS-ester sites for direct protein or oligonucleotide immobilization. The method allows efficient surface functionalization with high reproducibility, contributing to batch validation and traceability for regulatory clearance. Materials processed this way meet rigorous extractables/leachables (E&L) screening and biocompatibility testing for clinical laboratory use.

    Industry compliance standards

    • ISO 13485 Medical Devices—Quality Management Systems
    • ISO 10993 Biological Evaluation of Medical Devices
    • FDA 21 CFR Part 820 QSR
    • CLSI EP21 Laboratory Standards

    Typical usage ratio

    • 0.5–2.0 wt% in organic solution, depending on desired NHS-active density and substrate thickness. Determination based on substrate surface area and functional group concentration.

    Downstream process integration

    • Applied post-molding in surface-activated immersion or spray systems under controlled humidity to prevent premature hydrolysis.
    • Followed by curing and rinsing protocols according to ISO-certified cleanroom practices.
    • Incorporated into continuous production lines for high-throughput assay component fabrication.

    Final product types

    • NHS-activated ELISA plates
    • Lateral flow assay membranes
    • Magnetic particles for immunocapture
    • Functionalized polymer microbeads

    4. Oligonucleotide and Nucleic Acid Derivative Synthesis

    DNA and RNA oligonucleotide manufacturing facilities adopt N,N'-Disuccinimidyl Carbonate for activation and coupling steps in the production of custom-modified nucleic acids, especially those requiring amide, carbamate, or NHS-ester functionalization. The reliable reactivity profile supports high-throughput formulation for research, diagnostics, and therapeutic grade oligonucleotide APIs, where process traceability and minimization of synthesis byproducts play a key role in batch release and market authorization.

    Industry compliance standards

    • Chinese Pharmacopoeia (ChP) for oligonucleotide APIs
    • USP <1079> Good Storage and Distribution Practices for Bulk Oligonucleotides
    • GMP for Advanced Therapy Medicinal Products (EU Directive 2001/83/EC)
    • ISO 9001:2015 for contract synthesis QA

    Typical usage ratio

    • 1.0–1.3 molar equivalents relative to oligonucleotide terminal or internal group; fine-tuned by nucleotide load and desired substitution profile with analytical feedback.

    Downstream process integration

    • Introduced during automated solid-phase synthesis for block coupling, post-cleavage modification, or direct end-capping in anhydrous media.
    • Used pre-purification via ion-exchange or reverse-phase HPLC.
    • Managed within automated synthesis platforms under inert gas to minimize side-reactions.

    Final product types

    • Custom-labeled DNA probes
    • NHS-modified oligonucleotides for conjugate diagnostics
    • Therapeutic antisense oligos
    • Molecular biology gene editing components

    5. Polymer–Protein Conjugate Synthesis in Life Science Research

    Lab-scale and industrial players in the field of polymer–protein conjugates integrate this raw material for the introduction of NHS-active groups onto water-soluble polymers, such as PEGs or dendrimers, followed by protein or peptide coupling. This process achieves covalent linkage with defined stoichiometry, supporting development and commercial manufacturing of research reagents, drug delivery vehicles, and long-circulating biologics. End-product specifications demand analytical traceability for regulatory submission dossiers.

    Industry compliance standards

    • REACH/CLP (EC) No 1907/2006 for polymer safety data
    • ISO 9001 and ISO 14001 for process operations
    • US FDA IND/CMC filing requirements for drug delivery research
    • Sigma-Aldrich Technical Bulletin standards for life science reagents

    Typical usage ratio

    • 1.0–2.0 equivalents relative to available hydroxyl or amine groups on the polymer backbone; adjustment follows polymer chain length and desired substitution ratio for specific protein coupling.

    Downstream process integration

    • Deployed after polymer dissolution and pre-activation pH adjustment.
    • Followed by direct coupling with purified protein under controlled temperature conditions.
    • Multiple purification steps such as dialysis or ultrafiltration completed before bulk formulation.

    Final product types

    • PEGylated recombinant proteins
    • Dendrimer–enzyme conjugates
    • Polymer–antibody research tools
    • Drug delivery nanoparticle carriers
    Free Quote

    Competitive N,N'-Disuccinimidyl Carbonate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N,N'-Disuccinimidyl Carbonate: Setting a Standard in Peptide Coupling Chemistry

    Introducing Our Prime-Grade N,N'-Disuccinimidyl Carbonate

    At our production facility, every batch of N,N'-Disuccinimidyl Carbonate (DSC) gets its start from raw materials sourced with tight controls over purity and provenance. Those in the peptide synthesis community recognize DSC as a staple for its efficient activation of alcohols and amines, supporting the formation of carbamate or urea linkages without excessive byproduct buildup. We have refined our process to deliver high assay DSC with consistent fine crystalline morphology, free-flowing and low in residual solvents, so researchers and manufacturers avoid the burden of pre-processing or extra purification.

    Understanding the Details: Model, Purity, and Appearance

    Our DSC, produced in volumes suited both for bench-scale innovation and commercial manufacturing, comes in a standard purity of 99% minimum. Each batch exhibits a snow-white, characteristic crystalline powder form with minimal dust and no visible clumping—a result of controlled crystallization conditions adapted through years of direct feedback from users. Melting point typically ranges between 96°C and 100°C based on small changes in crystal size that we track batch-to-batch for quality control assurance. This persistent attention to details in the crystallization step yields an end product that’s easier to weigh, dissolve, and handle.

    Applications That Drive Chemical Innovation

    DSC’s chief appeal is its straightforward reactivity for carbamate formation without introducing moisture sensitivity or excess side-products seen with certain chloroformate reagents. Bioconjugation specialists depend on DSC as an activator in PEGylation. Pharmaceutical firms incorporate DSC in solid-phase peptide synthesis, and material scientists trust it for surface modifications on polymers. Conjugates built with DSC-activated linkers exhibit tighter reproducibility in yield because DSC hydrolyzes less rapidly compared with less-stable agents, making it practical for parallel automated platforms as well as challenging multi-step protocols.

    Manufacturing Perspective: Why DSC Actually Matters

    From our vantage point as a producer, DSC isn’t simply another commodity in the toolbox; it represents time savings and downstream clarity for scientists. When we discuss the nuts and bolts with customers, the conversations center on eliminating delays and cleaning up reaction profiles. Nobody wants to rerun purification columns because of traces of urea byproducts or persistent solvent residues. That’s why every DSC lot gets exhaustively dried under vacuum, followed by Karl Fischer titration to confirm water below 0.5%. Any user who’s had to salvage a sensitive protecting group due to unexpected hydrolysis will appreciate the predictability DSC gives.

    In many scale-up projects, switching from mixed anhydrides or carbonyldiimidazole to DSC cuts down workup complications due to fewer gaseous or acidic byproducts. Our technical team often works directly with process chemists to adapt DSC addition rates and agitation times, because even subtleties in mixing can affect coupling yields in large reactors. Those same lessons apply for smaller research labs: prompt, reproducible couplings mean less time lost optimizing conditions and more time discovering next-generation molecules.

    DSC vs. Similar Reagents: What Really Sets It Apart?

    There are plenty of options for carbamate or activated carbonate formation: carbonyldiimidazole (CDI), bis(p-nitrophenyl) carbonate, and phosgene analogues frequently come up in project plans. Yet, DSC leads in real-world handling and selectivity. By steering clear of aggressive acyl chloride chemistry, DSC sidesteps corrosive fumes, sideline acid scavengers, and excess salt waste. Where CDI releases imidazole—a moderately strong base that sometimes interferes with acid-sensitive intermediates—DSC leaves only NHS as a byproduct, which can usually be removed by water extraction, sidestepping tedious silica gel clean-ups.

    When we compared user feedback on conversion rates, DSC stands out in situations where you need precision: coupling amino alcohols for linker technologies, forming mono- or bis-carbamates with minimal overactivation, and assembling pre-activated esters for diagnostic intermediates. Peptide chemists favor DSC as an alternative to phosgene-based approaches, which demand extra engineering for gas handling and present tougher operator safety concerns. By sidestepping these hazards, DSC helps labs comply with strict safety regimes without major retrofits.

    Process Control: What Goes Into Making Reliable DSC?

    Drawing on continuous batch feedback, we’ve dialed in parameters for DSC that match both pharmaceutical and diagnostics supplier requirements. This centers around exclusion of water and the precise rate of incorporation of succinimide. Any deviation introduces colored impurities—one look at a tan or off-white powder tells an experienced user that their downstream column load will double. DSC’s sensitivity in storage guides every output stage to be completed under inert gas and stored cool, with tightly traceable shelf lives assigned from actual hydrolysis rate studies using NMR titration benchmarks.

    Beyond production, every lot’s stability is tracked for at least 24 months, designed for real-world usage patterns in ambient-equipped labs around the world. It’s not only about initial analysis, but confirming months or years down the line that DSC performs as tightly as the day it arrived—a factor that far too often distinguishes bulk producers from those who only repackage material.

    From Pilot to Full-Scale: Addressing Key User Pain Points

    Some buyers chase after low-CAS DSC from traders, only to fight solubility inconsistencies and patches of off-odors bound to solvent residues left from improper drying. We’ve seen more than a few pilot batches grind to a halt while labs scramble to explain sluggish coupling or unexplained chromatographic peaks. By comparison, DSC made with comprehensive drying and real end-point chromatography unlocks better batch-to-batch consistency. Experienced users recognize how a few extra hours of low-vacuum finish can save workweeks in downstream troubleshooting. Our clients are quick to point out, in confidential settings, that once their teams switched to our DSC, column waste dropped and final yields standardized across lots.

    In custom synthesis, steady availability and traceability matter. We supply major projects from a single campaign batch whenever possible, linking trace data from raw materials up through finished DSC so that large customers can streamline audit reporting. That sort of forward trace—from source to finished container—distinguishes a chemical manufacturer who handles all synthesis in-house.

    Practical Workflow: DSC in Your Synthetic Scheme

    Researchers prepping carbamate-protected building blocks often pair DSC with amines or alcohols. We routinely collaborate to fine-tune loading equivalents and quenching order during scale-up—even temperature ramps can shift selectivity or kinetics. For example, some opt for room temp activation, while others push to 40°C for stubborn nucleophiles. Each unique chemical environment calls for small tweaks, and our technical support keeps pace, offering direct talk rather than template advice. We monitor the hydrolytic stability of DSC in DMAc and DMF, with recommended moisture limits published based on our own titrated benchmarks.

    Scalability is a frequently overlooked edge. With DSC, a well-managed solvent delivery paired with in-situ intermediate formation keeps exotherms controlled and operator exposure minimal. In the rare cases where our partners report out-of-spec conversion, we dive into sampling and solvent purity checks, not just point to the popular assumption that “all DSC is the same.”

    Why Chemists Return to Proven DSC Batches

    Chemists in both academia and industry circle back to trusted DSC batches because the cost of a failed coupling—dropped columns or ruined intermediates—exceeds any short-term savings from gray-market suppliers. A robust, high-purity DSC eliminates guesswork. We’ve witnessed customers pull material from different vendors and run side-by-side couplings, then discover only one yields the same chromatogram every time. That repeatability traces directly to origin, control at every handling step, and transparent documentation on every drum or bottle.

    Years of firsthand feedback convinced us to embed more sampling points in purification and instate regular spot-checks on packed bottles. Each time a user highlights that their carbamate product comes out crystal-clear and free from persistent unknown peaks, it affirms what we worked hard to establish: real, controllable quality that carries through every application.

    Improving Downstream Manufacturing with Upstream Consistency

    DSC is sometimes overlooked in the cost accounting phase. Some project leads focus on per-kilogram costs but ignore the hidden losses from labor, repeat work, or disposal costs tied to inferior lots. Our downstream partners in advanced intermediates highlight how consistent DSC directly improves ROI on large-scale synthesis, especially with labor-intensive solid-phase chemistry where each step multiplies a tiny inconsistency into lost final product.

    We see the same story repeat in antibody-drug conjugate manufacturing, fine-tuning PEGylation reactions where the efficiency of the linking agent controls overall product throughput. Missing a step due to a slow-reacting or water-compromised carbonate brings large-batch lots to a standstill and sets back delivery targets for critical projects. This is all the more important as regulatory demands tighten for reproducibility and GMP traceability: subpar DSC carries real business risks.

    Supporting Evolving Applications in Bioconjugation and Diagnostics

    DSC’s low byproduct profile and gentle activation make it a preferred agent for emerging diagnostic probes and next-generation linker assemblies in biologics. As detection standards rise and analytical endpoints require rigorously low levels of residuals, the feedback from device manufacturers echoes: high assay, stable DSC means fewer artifacts, clearer spectra, and shorter validation times for new test platforms. Such considerations aren’t marketing claims—they’re borne out across independent lab validations and regulatory submissions incorporating our DSC.

    With new classes of targeted payloads reaching clinical trial phases, any coupling agent must check the boxes for purity, stability, and documented consistency. DSC is now entrenched as a tool of choice for assembling functionalized polymers, labeled oligonucleotides, and cleavable linkers for time-resolved release. Our in-house R&D continues to adapt crystallization and drying methods to respond to the shifting benchmarks imposed by stricter regulators and motivated scientists.

    Environmental and Operator Safety Benefits: DSC’s Strategic Role

    Production settings often bring environmental priorities into sharp focus. DSC scores well compared to traditional phosgene-based carbonates: the absence of toxic gas generation means less worry over air handling, no need for gas-absorber columns, and reduced operator hazard, which fits into internal safety audits and satisfies more rigorous environmental assessments. Users who’ve shifted to DSC from hazardous carbonylation agents often report easier compliance with local emission rules—a practical win for project continuity and personnel morale alike.

    From a waste handling angle, more benign NHS byproducts are simple to treat. Our own waste stream management protocols make use of this ease, allowing DSC operations to slot into multi-step plants without significant reconfiguration or specialty effluent treatment systems.

    Working Directly with Manufacturer Know-How

    As a manufacturer with deep roots in process chemistry, we know what questions keep researchers up at night: “Will my DSC work every time?” “Am I introducing new side reactions?” “Is this batch stable through all my planned steps?” We’re used to making annual commitment batches for repeat customers whose planning horizons depend on tight specs and documented performance. No batch leaves our gates without passing full NMR purity, melting point analysis, and residual moisture checks.

    Direct feedback loops from users keep our production teams alert for trends and evolving problems. If a major downstream player flags even subtle solubility changes over a year of storage, we investigate drying cycle data, not just label new expiration dates. This hands-on, transparent approach—no shortcuts, no rebranded stock—anchors everything about our DSC.

    Driving Reliability and Progress in Synthesis

    A well-prepared DSC source eliminates recurring pain points in organic synthesis and bioconjugation. The value emerges not from abstract quality claims, but in the smooth flow of project milestones, the ability to skip redundant purifications, and the confidence that each drum or vial matches the last. As new challenges in coupling chemistry emerge, we remain committed to advancing not just process chemistry but reliability itself. Our focus remains on producing N,N'-Disuccinimidyl Carbonate in ways that reduce site-to-site variability, support robust data packages, and support next-generation research with practical, real results every step of the way.